229 related articles for article (PubMed ID: 9066602)
1. Luminal epithelial antigen (LEA.135) expression correlates with tumor progression for transitional carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Anticancer Res; 1997; 17(1B):685-7. PubMed ID: 9066602
[TBL] [Abstract][Full Text] [Related]
2. Luminal epithelial antigen (LEA.135) expression in adenocarcinoma of the colon.
Miles SE; Kenwright DN; Gaskell DJ; Christie RM; Thornton A; Delahunt B
Anticancer Res; 1999; 19(1A):597-600. PubMed ID: 10226604
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
[TBL] [Abstract][Full Text] [Related]
4. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
5. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
Zhang H; Zhao Z; Sun H
Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal Ki-67 expression in transitional cell carcinoma of the bladder.
Jones HL; Delahunt B; Bethwaite PB; Thornton A
Pathology; 1997 Feb; 29(1):84-7. PubMed ID: 9094186
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
Kuncová J; Urban M; Mandys V
APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
10. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
11. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.
Krüger S; Mahnken A; Kausch I; Feller AC
Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
13. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer.
Imam SA; Esteban EF; Chen RS; Cardiff RD; Taylor CR
Cancer Res; 1993 Jul; 53(14):3233-6. PubMed ID: 7686814
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
Elsamman E; Fukumori T; Kasai T; Nakatsuji H; Nishitani MA; Toida K; Ali N; Kanayama HO
BJU Int; 2006 Jun; 97(6):1202-7. PubMed ID: 16686711
[TBL] [Abstract][Full Text] [Related]
16. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma].
Yuge F; Hirakata H; Igarashi H; Kodama M; Kawata N; Takimoto Y
Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
Mahnken A; Kausch I; Feller AC; Krüger S
Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373
[TBL] [Abstract][Full Text] [Related]
20. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
